Survival analysis of patients with differentiated thyroid carcinoma based on the risk stratification

被引：0
|
作者：
Farmakis, G. [1 ]
Gouverneur, E. [1 ]
Thiele, J. [1 ]
Hellwig, D. [1 ]
Kirsch, C. [1 ]
机构：
[1] Univ Saarland, Med Ctr, D-6650 Homburg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S451 / S451
页数：1
相关论文
共 50 条
  • [31] A predictive model and survival analysis for local recurrence in differentiated thyroid carcinoma
    Yang, Peipei
    Huang, Jiuping
    Wang, Zhendong
    Qian, Linxue
    MINERVA ENDOCRINOLOGY, 2022, 47 (03): : 286 - 294
  • [32] Survival and death causes in differentiated thyroid carcinoma
    Eustatia-Rutten, CFA
    Corssmit, EPM
    Biermasz, NR
    Pereira, AM
    Romijn, JA
    Smit, JW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01): : 313 - 319
  • [33] Risk group-based management of differentiated thyroid carcinoma
    Kuriakose, MA
    Hicks, WL
    Loree, TR
    Yee, H
    JOURNAL OF THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH, 2001, 46 (04): : 216 - 223
  • [34] Patterns of failure in differentiated carcinoma of the thyroid based on risk groups
    Shaha, AR
    Shah, JP
    Loree, TR
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1998, 20 (01): : 26 - 30
  • [35] Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis
    Staubitz, Julia I.
    Mueller, Celine
    Heymans, Antonia
    Merten, Christina
    Roos, Bianca
    Poplawski, Alicia
    Ludt, Annekathrin
    Strobl, Stephanie
    Springer, Erik
    Schad, Arno
    Roth, Wilfried
    Musholt, Thomas J.
    Hartmann, Nils
    BJS OPEN, 2023, 7 (03):
  • [36] How reliable is secondary risk stratification with stimulated thyroglobulin in patients with differentiated thyroid carcinoma? Results from a retrospective study
    Lemb, J.
    Huefner, M.
    Meller, B.
    Homayounfar, K.
    Sahlmann, C.
    Meller, J.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2013, 52 (03): : 88 - 96
  • [37] The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence
    Kowalska, Aldona
    Walczyk, Agnieszka
    Palyga, Iwona
    Gasior-Perczak, Danuta
    Gadawska-Juszczyk, Klaudia
    Szymonek, Monika
    Trybek, Tomasz
    Lizis-Kolus, Katarzyna
    Szyska-Skrobot, Dorota
    Mikina, Estera
    Hurej, Stefan
    Sluszniak, Janusz
    Mezyk, Ryszard
    Gozdz, Stanislaw
    PLOS ONE, 2016, 11 (04):
  • [38] Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients
    Kelly, Antony
    Barres, Bertrand
    Kwiatkowski, Fabrice
    Batisse-Lignier, Marie
    Aubert, Bernadette
    Valla, Clemence
    Somda, Frederic
    Cachin, Florent
    Tauveron, Igor
    Maqdasy, Salwan
    PLOS ONE, 2019, 14 (08):
  • [39] THE EFFECT OF THYROID-HORMONE ADMINISTRATION UPON SURVIVAL IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA
    CADY, B
    COHN, K
    ROSSI, RL
    SEDGWICK, CE
    MEISSNER, WA
    WERBER, J
    GELMAN, RS
    SURGERY, 1983, 94 (06) : 978 - 983
  • [40] Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine
    Momesso, Denise P.
    Vaisman, Fernanda
    Yang, Samantha P.
    Bulzico, Daniel A.
    Corbo, Rossana
    Vaisman, Mario
    Tuttle, R. Michael
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (07): : 2692 - 2700
12345